Anewa Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 8 Months 25 Days
About Anewa Lifesciences
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Linga Churukanti, Likhith Thuraga, Lakshmi Thuraga, and One other member serve as directors at the Company.
- CIN/LLPIN
U21001TS2024PTC183751
- Company No.
183751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anewa Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Linga Churukanti  | Director | 26-Mar-2024 | Current |
Likhith Thuraga  | Director | 26-Mar-2024 | Current |
| Lakshmi Thuraga | Director | 26-Mar-2024 | Current |
| Mulamalla Reddy | Director | 26-Mar-2024 | Current |
Financial Performance and Corporate Structure Insights of Anewa Lifesciences.
Enhance accessibility to Anewa Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anewa Lifesciences?
Unlock access to Anewa Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Quinnharper Pharmaceuticals Private LimitedActive 8 months 19 daysLinga Churukanti is a mutual person
- Bio-Vin Pharmaceuticals (Hyderabad) Private LimitedActive 16 years 3 months
Linga Churukanti and Mulamalla Reddy are mutual person
- Bio-Vin Research Laboratories Private LimitedActive 16 years 10 months
Linga Churukanti and Mulamalla Reddy are mutual person
- Cgs Assets Private LimitedActive 14 years 3 months
Linga Churukanti and Mulamalla Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anewa Lifesciences?
Unlock and access historical data on people associated with Anewa Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anewa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anewa Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
